Equities research analysts at StockNews.com started coverage on shares of NovaBay Pharmaceuticals (NYSEAMERICAN:NBY – Get Rating) in a research report issued on Thursday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. NovaBay Pharmaceuticals Trading Down 1.4 % NBY stock opened at $0.68 on Thursday. The stock has a 50-day moving average price […]